The United Sorghum Checkoff Program has launched the first-ever human clinical trial on whole-grain sorghum, led by the University of Nebraska–Lincoln and co-funded with USDA’s AFRI Commodity Board, comparing daily intake of sorghum in adults with obesity to track insulin resistance, inflammation, and gut microbiome shifts. Lanier Dabruzzi, MS, RD, LD is the Director of Nutrition & Food Innovation at The United Sorghum Checkoff Program.
She joined Jesse Allen for a conversation on AOA about this trial and what it could mean for sorghum as part of a healthy diet moving forward.
***You can hear the audio of the conversation on the Tuesday, October 28th, 2025 episode of AOA below:
Details on First-Ever Human Clinical Trial for Ancient Grain
The United Sorghum Checkoff Program has launched the first-ever human clinical trial on whole-grain sorghum, led by the University of Nebraska–Lincoln and co-funded with USDA’s AFRI Commodity Board, comparing daily intake of sorghum in adults with obesity to track insulin resistance, inflammation, and gut microbiome shifts. Lanier Dabruzzi, MS, RD, LD is the Director of Nutrition & Food Innovation at The United Sorghum Checkoff Program.
She joined Jesse Allen for a conversation on AOA about this trial and what it could mean for sorghum as part of a healthy diet moving forward.
***You can hear the audio of the conversation on the Tuesday, October 28th, 2025 episode of AOA below:
Recommended Posts
Protect Your Farm’s Legacy With Sound Decisions
FBN Releases Crop Protection Report
FarmPath – Building the Next Generation of Farmers
Beef Demand and the Direct-to-Consumer Model